Rezolute to Participate in the Citizens Life Sciences Conference

Company Overview - Rezolute, Inc. is a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism (HI) [3] - The company's antibody therapy, ersodetug, is designed to treat all forms of HI and has been studied in clinical trials and real-world cases for both congenital and tumor HI [3] Upcoming Events - Management will participate in the Citizens Life Sciences Conference on March 10-11, 2026, in Miami, FL [1] - One-on-one investor meetings will be held throughout the conference, and interested investors can contact their Citizens representative to schedule a meeting [2]